Adults with genetic disorder PKU need to get back to the clinic

Aug 26, 2009

Genetic researchers at Children's Memorial Hospital, Chicago, are aggressively identifying adult patients who suffer from the genetic disorder, Phenylketonuria (PKU), and are presenting those findings at the 11th International Congress of Inborn Errors of Metabolism in San Diego, August 29 through September 2.

The findings have also been published in the current issue of and Metabolism.

PKU is a lifelong in which a deficient enzyme prevents the body from metabolizing an essential amino acid, called Phenylalanine (Phe), which is found in most foods including meat, bread, eggs, dairy, nuts, and some fruits and vegetables. When left untreated, PKU patients who consume too much Phe are at risk for severe neurological complications, including IQ loss, memory loss, concentration problems, mood disorders, and in some cases, severe mental retardation.

Barbara Burton, MD, Director of the PKU and Metabolic Disease Program at Children's Memorial and Lauren Leviton, Education Coordinator in the Division of Genetics at Children's Memorial lead the adult PKU Outreach program. Through the program, the team has been able to identify and treat several adult PKU patients who have returned to treatment.

"It is so important for adults with PKU to know that it is never too late to address the disorder and resume treatment," said Dr. Burton. "When PKU is no longer managed, that is when we see patients who suffer from mood and social disorders. For adults, this can also impact their concentration at work, stability in relationships and social interactions. As a healthcare provider, I feel that it is our responsibility to educate adult PKU patients and offer comprehensive medical care and social support systems."

Full results and an overview of how to develop such a program will be presented at the Congress.

Source: Children's Memorial Hospital

Explore further: Comparing deep vein thrombosis treatments

add to favorites email to friend print save as pdf

Related Stories

Study reveals new options for people with PKU

Mar 30, 2009

(PhysOrg.com) -- For people with the genetic condition known as phenylketonuria (PKU), diet is a constant struggle. They can eat virtually no protein, and instead get their daily dose of this key macronutrient by drinking ...

Drug therapy for PKU reverses heart damage

May 13, 2008

A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns ...

Drug reverses mental retardation caused by genetic disorder

Jun 22, 2008

[B]UCLA mouse study offers hope for correcting how autism disrupts brain[/B] UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis com ...

Recommended for you

Asthma drug may help those with chronic hives

11 hours ago

(HealthDay)—A drug already used to treat moderate-to-severe allergic asthma appears to offer relief to people with chronic hives who haven't been helped by standard medications, new research suggests.

Study compares deep vein thrombosis therapies (Update)

14 hours ago

Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that ...

User comments : 0